TVTX
Travere Therapeutics Inc.
Latest News for TVTX
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Travere Therapeutics today and set a price target of $47.00. According to TipRa......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Travere Therapeutics (TVTX – Research Report) and Bo......
In a report released yesterday, Vamil Divan from Guggenheim reiterated a Buy rating on Travere Therapeutics, with a price target of $49.00. The com......
Travere Therapeutics ( ($TVTX) ) has issued an announcement. On January 13, 2026, Travere Therapeutics announced that the U.S. Food and Drug Admini......
Shares in Travere Therapeutics ($TVTX) plunged over 33% on Tuesday after U.S. health watchdog extended its decision date for the biotech firm’s FIL......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Argenx Se (ARGX – Research Report), Travere Therapeu......
Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Travere Therapeutics today and set a price target of $42.00. According to TipRa......
In a report released today, Mohit Bansal from Wells Fargo maintained a Buy rating on Travere Therapeutics, with a price target of $40.00. Bansal co......
Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Travere Therapeutics today and set a price target of $47.00. Zemansky ......
News data is sourced from MarketXLS API and updated regularly.
Showing 9 of 9 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TVTX | $32.73 | -1.1% | 1.20M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Travere Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW